ultra-fast enzyme engineering platform
Imperagen has raised €9.9M across 2 funding rounds from 3 investors, most recently a Seed round in May 2026. Based in Manchester, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-05-21 | Seed | €5.8M | IQ Capital,Northern Gritstone,PXN Ventures | View deal → |
| 2022-08-09 | Seed | €4.1M | IQ Capital,Northern Gritstone | View deal → |
